You have free access to this content

Hepatology

Cover image for Hepatology

September 2009

Volume 50, Issue 3

Pages 661–995

  1. Practice Guideline Update

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Chronic hepatitis B: Update 2009 (pages 661–662)

      Anna S. F. Lok and Brian J. McMahon

      Version of Record online: 28 JUL 2009 | DOI: 10.1002/hep.23190

  2. Comments from the Editors

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      What's in a NAme? (pages 663–667)

      Elizabeth M. Brunt

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23070

  3. Editorials

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      The many faces of hepatitis C: Liver disease and type 2 diabetes (pages 668–670)

      Kerry-Lee Milner, Donald Chisholm and Jacob George

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23117

    2. You have free access to this content
    3. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase (pages 678–688)

      Masahiko Yano, Masanori Ikeda, Ken-ichi Abe, Yoshinari Kawai, Misao Kuroki, Kyoko Mori, Hiromichi Dansako, Yasuo Ariumi, Shougo Ohkoshi, Yutaka Aoyagi and Nobuyuki Kato

      Version of Record online: 17 APR 2009 | DOI: 10.1002/hep.23026

    2. You have free access to this content
      Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus (pages 689–696)

      Hussein Hassan Aly, Yue Qi, Kimie Atsuzawa, Nobuteru Usuda, Yasutsugu Takada, Masashi Mizokami, Kunitada Shimotohno and Makoto Hijikata

      Version of Record online: 17 APR 2009 | DOI: 10.1002/hep.23034

    3. You have free access to this content
      Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C (pages 697–706)

      Ester Vanni, Maria Lorena Abate, Elena Gentilcore, Ingrid Hickman, Roberto Gambino, Maurizio Cassader, Antonina Smedile, Ele Ferrannini, Mario Rizzetto, Giulio Marchesini, Amalia Gastaldelli and Elisabetta Bugianesi

      Version of Record online: 17 APR 2009 | DOI: 10.1002/hep.23031

    4. You have free access to this content
      Degree of cross-genotype reactivity of hepatitis C virus–specific CD8+ T cells directed against NS3 (pages 707–716)

      Silvia Giugliano, Filiz Oezkan, Mathias Bedrejowski, Markus Kudla, Markus Reiser, Sergei Viazov, Norbert Scherbaum, Michael Roggendorf and Joerg Timm

      Version of Record online: 29 MAY 2009 | DOI: 10.1002/hep.23096

    5. You have free access to this content
      A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results (pages 717–726)

      Yves Benhamou, Nezam H. Afdhal, David R. Nelson, Mitchell L. Shiffman, Deanine G. Halliman, Jamie Heise, Eric Chun and Paul J. Pockros

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23073

    6. You have free access to this content
      Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil (pages 727–734)

      Nghi B. Ha, Nghiem B. Ha, Ruel T. Garcia, Huy N. Trinh, Andrew A. Vu, Huy A. Nguyen, Khanh K. Nguyen, Brian S. Levitt and Mindie H. Nguyen

      Version of Record online: 24 APR 2009 | DOI: 10.1002/hep.23044

    7. You have free access to this content
      CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection (pages 735–742)

      Dongling Li, Linghua Zheng, Lei Jin, Yuesu Zhou, Haiying Li, Junliang Fu, Ming Shi, Peishuang Du, Lizhong Wang, Hao Wu, Guo-Yun Chen, Pan Zheng, Yang Liu, Fu-Sheng Wang and Shengdian Wang

      Version of Record online: 27 APR 2009 | DOI: 10.1002/hep.23047

    8. You have free access to this content
      Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B (pages 743–751)

      Mehlika Toy, Irene K. Veldhuijzen, Robert A. de Man, Jan Hendrik Richardus and Solko W. Schalm

      Version of Record online: 6 MAY 2009 | DOI: 10.1002/hep.23061

    9. You have free access to this content
      Large liver cell change in hepatitis B virus–related liver cirrhosis (pages 752–762)

      Haeryoung Kim, Bong-Kyeong Oh, Massimo Roncalli, Chanil Park, So-Mi Yoon, Jeong Eun Yoo and Young Nyun Park

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23072

    10. You have free access to this content
  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis (pages 772–780)

      Koji Fujita, Yuichi Nozaki, Koichiro Wada, Masato Yoneda, Yoko Fujimoto, Mihoyo Fujitake, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito and Atsushi Nakajima

      Version of Record online: 28 MAY 2009 | DOI: 10.1002/hep.23094

    2. You have free access to this content
      Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes (pages 781–790)

      Janin Henkel, Frank Neuschäfer-Rube, Andrea Pathe-Neuschäfer-Rube and Gerhard P. Püschel

      Version of Record online: 6 MAY 2009 | DOI: 10.1002/hep.23064

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma (pages 791–798)

      Jordi Rimola, Alejandro Forner, Maria Reig, Ramon Vilana, Carlos Rodríguez de Lope, Carmen Ayuso and Jordi Bruix

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23071

    2. You have free access to this content
      Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor (pages 799–807)

      Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten and Firouzeh Korangy

      Version of Record online: 1 MAY 2009 | DOI: 10.1002/hep.23054

  7. Autoimmune, Cholestatic, and Biliary Disease

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis (pages 808–814)

      Keith D. Lindor, Kris V. Kowdley, Velimir A. C. Luketic, M. Edwyn Harrison, Timothy McCashland, Alex S. Befeler, Denise Harnois, Roberta Jorgensen, Jan Petz, Jill Keach, Jody Mooney, Carol Sargeant, Julie Braaten, Tamara Bernard, Debra King, Ellen Miceli, Jeff Schmoll, Tanya Hoskin, Prabin Thapa and Felicity Enders

      Version of Record online: 20 MAY 2009 | DOI: 10.1002/hep.23082

    2. You have free access to this content
      Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon (pages 815–824)

      Xia Wang, Debi P. Sarkar, Prashant Mani, Clifford J. Steer, Yong Chen, Chandan Guha, Voshavar Chandrasekhar, Arabinda Chaudhuri, Namita Roy-Chowdhury, Betsy T. Kren and Jayanta Roy-Chowdhury

      Version of Record online: 6 MAY 2009 | DOI: 10.1002/hep.23060

  8. Liver Failure, Cirrhosis and Portal Hypertension

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed (pages 825–833)

      Dhiraj Tripathi, James W. Ferguson, Narendra Kochar, Joanna A. Leithead, George Therapondos, Norma C. Mcavoy, Adrian J. Stanley, Ewan H. Forrest, William S. Hislop, Peter R. Mills and Peter C. Hayes

      Version of Record online: 24 APR 2009 | DOI: 10.1002/hep.23045

  9. Liver Injury/Regeneration

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor (pages 834–843)

      Guiying Li, Chang Han, Lihong Xu, Kyu Lim, Kumiko Isse and Tong Wu

      Version of Record online: 1 MAY 2009 | DOI: 10.1002/hep.23052

    2. You have free access to this content
      Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase (pages 844–851)

      Udayan Apte, Vasiliki Gkretsi, William C. Bowen, Wendy M. Mars, Jian-Hua Luo, Shashikiran Donthamsetty, Ann Orr, Satdarshan P.S. Monga, Chuanyue Wu and George K. Michalopoulos

      Version of Record online: 6 MAY 2009 | DOI: 10.1002/hep.23059

    3. You have free access to this content
      Conditional deletion of ferritin H in mice induces loss of iron storage and liver damage (pages 852–860)

      Deepak Darshan, Liviu Vanoaica, Larry Richman, Friedrich Beermann and Lukas C. Kühn

      Version of Record online: 6 MAY 2009 | DOI: 10.1002/hep.23058

  10. Liver Biology/Pathobiology

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders (pages 861–870)

      Verena Keitel, Kenko Cupisti, Christoph Ullmer, Wolfram T. Knoefel, Ralf Kubitz and Dieter Häussinger

      Version of Record online: 17 APR 2009 | DOI: 10.1002/hep.23032

    2. You have free access to this content
      Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice (pages 871–879)

      Jan S. Tchorz, Jochen Kinter, Matthias Müller, Luigi Tornillo, Markus H. Heim and Bernhard Bettler

      Version of Record online: 27 APR 2009 | DOI: 10.1002/hep.23048

    3. You have free access to this content
      Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate–activated protein kinase–dependent induction of orphan nuclear receptor small heterodimer partner (pages 880–892)

      Dipanjan Chanda, Chul Ho Lee, Yong-Hoon Kim, Jung-Ran Noh, Don-Kyu Kim, Ji-Hoon Park, Jung Hwan Hwang, Mi-Ran Lee, Kyeong-Hoon Jeong, In-Kyu Lee, Gi Ryang Kweon, Minho Shong, Goo-Taeg Oh, John Y. L. Chiang and Hueng-Sik Choi

      Version of Record online: 27 APR 2009 | DOI: 10.1002/hep.23049

    4. You have free access to this content
      The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice (pages 893–899)

      Peter Fickert, Andrea Fuchsbichler, Martin Wagner, Dagmar Silbert, Kurt Zatloukal, Helmut Denk and Michael Trauner

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23068

    5. You have free access to this content
      Porcine liver sinusoidal endothelial cells contribute significantly to intrahepatic ammonia metabolism (pages 900–908)

      Geir I. Nedredal, Kjetil Elvevold, Lars M. Ytrebø, Ole-Martin Fuskevåg, Ingvild Pettersen, Peter A. G. McCourt, Kjell Bertheussen, Bård Smedsrød and Arthur Revhaug

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23076

    6. You have free access to this content
      Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells (pages 909–919)

      Anna Schurich, Jan P. Böttcher, Sven Burgdorf, Patrick Penzler, Silke Hegenbarth, Michaela Kern, Andreas Dolf, Elmar Endl, Joachim Schultze, Emmanuel Wiertz, Dirk Stabenow, Christian Kurts and Percy Knolle

      Version of Record online: 11 MAY 2009 | DOI: 10.1002/hep.23075

    7. You have free access to this content
      Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro (pages 920–928)

      Sandra March, Elliot E. Hui, Gregory H. Underhill, Salman Khetani and Sangeeta N. Bhatia

      Version of Record online: 20 MAY 2009 | DOI: 10.1002/hep.23085

    8. You have free access to this content
      Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice (pages 929–938)

      Christoph H. Österreicher, Kojiro Taura, Samuele De Minicis, Ekihiro Seki, Melitta Penz-Österreicher, Yuzo Kodama, Johannes Kluwe, Manfred Schuster, Gavin Y. Oudit, Josef M. Penninger and David A. Brenner

      Version of Record online: 28 MAY 2009 | DOI: 10.1002/hep.23104

    9. You have free access to this content
      Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes (pages 939–947)

      ZhenYue Tong, Ruju Chen, Daniel S. Alt, Sherri Kemper, Bernard Perbal and David R. Brigstock

      Version of Record online: 28 MAY 2009 | DOI: 10.1002/hep.23102

    10. You have free access to this content
      Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump (pages 948–956)

      Renxue Wang, Huey-Ling Chen, Lin Liu, Jonathan A. Sheps, M. James Phillips and Victor Ling

      Version of Record online: 20 MAY 2009 | DOI: 10.1002/hep.23089

  11. Reviews

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Adipokines in liver diseases (pages 957–969)

      Fabio Marra and Cristiana Bertolani

      Version of Record online: 27 APR 2009 | DOI: 10.1002/hep.23046

    2. You have free access to this content
  12. Hepatology Elsewhere

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      TAL deficiency, all roads lead to oxidative stress? (pages 979–981)

      Maximilian Hatting, Christian Trautwein and Francisco Javier Cubero

      Version of Record online: 27 AUG 2009 | DOI: 10.1002/hep.23227

    2. You have free access to this content
  13. Image of the Month

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Hepatic Gaucheroma mimicking focal nodular hyperplasia (pages 985–986)

      Ludger Wilhelm Poll and Stephan vom Dahl

      Version of Record online: 20 JUL 2009 | DOI: 10.1002/hep.23183

  14. Correspondence

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
    2. You have free access to this content
      Reply: (pages 987–988)

      Xiaoying Zhang and Shuhan Sun

      Version of Record online: 24 JUN 2009 | DOI: 10.1002/hep.23141

    3. You have free access to this content
    4. You have free access to this content
      Reply: (pages 988–989)

      Bruce R. Bacon

      Version of Record online: 2 JUL 2009 | DOI: 10.1002/hep.23149

    5. You have free access to this content
    6. You have free access to this content
      Reply: (pages 989–990)

      Amalia Gastaldelli, Giorgio Bedogni and Beverley Balkau

      Version of Record online: 7 JUL 2009 | DOI: 10.1002/hep.23154

    7. You have free access to this content
    8. You have free access to this content
      An apoptosis biomarker for prediction of nonalcoholic steatohepatitis (page 991)

      Heike Bantel, Matthias J. Bahr and Klaus Schulze-Osthoff

      Version of Record online: 26 MAY 2009 | DOI: 10.1002/hep.23092

    9. You have free access to this content
      Human liver stem cells originate from the canals of hering (pages 992–993)

      Nimantha De Alwis, Gavin Hudson, Alastair D. Burt, Christopher P. Day and Patrick F. Chinnery

      Version of Record online: 7 JUL 2009 | DOI: 10.1002/hep.23160

    10. You have free access to this content
    11. You have free access to this content
      Reply: (page 994)

      Manal M. Hassan and James L Abbruzzese

      Version of Record online: 20 JUL 2009 | DOI: 10.1002/hep.23172

  15. Correction

    1. Top of page
    2. Practice Guideline Update
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic, and Biliary Disease
    9. Liver Failure, Cirrhosis and Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Reviews
    13. Hepatology Elsewhere
    14. Image of the Month
    15. Correspondence
    16. Correction
    1. You have free access to this content
      Correction (pages 994–995)

      Version of Record online: 27 JUL 2009 | DOI: 10.1002/hep.23155

    2. You have free access to this content
      Correction (page 995)

      Version of Record online: 20 JUL 2009 | DOI: 10.1002/hep.23179

SEARCH

SEARCH BY CITATION